SANGAMO THERAPEUTICS, INC Quarterly Deferred Income Tax Liabilities, Net in USD from Q4 2018 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.
Summary
Sangamo Therapeutics, Inc quarterly Deferred Income Tax Liabilities, Net history and growth rate from Q4 2018 to Q4 2023.
  • Sangamo Therapeutics, Inc Deferred Income Tax Liabilities, Net for the quarter ending December 31, 2023 was $0.000, a 100% decline year-over-year.
Deferred Income Tax Liabilities, Net, Quarterly (USD)
Deferred Income Tax Liabilities, Net, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $0 -$6.27M -100% Dec 31, 2023 10-K 2024-03-13
Q3 2023 $0 -$5.74M -100% Sep 30, 2023 10-Q 2023-11-01
Q2 2023 $0 -$6.12M -100% Jun 30, 2023 10-Q 2023-08-08
Q1 2023 $6.37M -$139K -2.14% Mar 31, 2023 10-Q 2023-05-08
Q4 2022 $6.27M -$375K -5.64% Dec 31, 2022 10-K 2024-03-13
Q3 2022 $5.74M -$1.05M -15.5% Sep 30, 2022 10-Q 2022-11-03
Q2 2022 $6.12M -$837K -12% Jun 30, 2022 10-Q 2022-08-04
Q1 2022 $6.51M -$359K -5.23% Mar 31, 2022 10-Q 2022-05-05
Q4 2021 $6.65M -$540K -7.52% Dec 31, 2021 10-K 2023-02-23
Q3 2021 $6.79M -$79K -1.15% Sep 30, 2021 10-Q 2021-11-04
Q2 2021 $6.96M +$381K +5.79% Jun 30, 2021 10-Q 2021-08-05
Q1 2021 $6.87M +$426K +6.61% Mar 31, 2021 10-Q 2021-05-04
Q4 2020 $7.19M +$615K +9.36% Dec 31, 2020 10-K 2022-02-24
Q3 2020 $6.87M +$473K +7.4% Sep 30, 2020 10-Q 2020-11-04
Q2 2020 $6.58M -$83K -1.25% Jun 30, 2020 10-Q 2020-08-05
Q1 2020 $6.44M Mar 31, 2020 10-Q 2020-05-11
Q4 2019 $6.57M -$135K -2.01% Dec 31, 2019 10-K 2021-02-24
Q3 2019 $6.4M Sep 30, 2019 10-Q 2019-11-06
Q2 2019 $6.66M Jun 30, 2019 10-Q 2019-08-07
Q4 2018 $6.71M Dec 31, 2018 10-Q 2019-11-06
* An asterisk sign (*) next to the value indicates that the value is likely invalid.